Condition: Stomach Cancer · Undifferentiated Type · Expanded Indication of Endoscopic Resection · Sponsor: National Cancer Center, Korea
This multi-center, randomized controlled trial is designed to evaluate clinical effectiveness and cost-effectiveness of ESD for undifferentiated type of EGC meeting the expanded indication compared with surgery.
This description comes directly from the study's public registry record.
Il Ju Choi, MD, PhD · +82-31-920-2282 · cij1224@ncc.re.kr
Young-Il Kim, MD, PhD · +82-31-920-1712 · 11996@ncc.re.kr
Always discuss trial participation with your own doctor first.
| National Cancer Center, Korea | Goyang-si, Gyeonggi-do, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04890171